| 
Citations
 | 
   web
Vershkov, D., & Benvenisty, N. (2017). Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome. Regen Med, 12(1), 53–68.
toggle visibility
Thomas, A. A., Abrey, L. E., Terziev, R., Raizer, J., Martinez, N. L., Forsyth, P., et al. (2017). Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol, 19(10), 1380–1390.
toggle visibility
Tahara, T., Hirata, I., Nakano, N., Nagasaka, M., Nakagawa, Y., Shibata, T., et al. (2017). Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis. Inflamm Bowel Dis, 23(1), 165–173.
toggle visibility
Sullivan, K. E., Rojas, K., Cerione, R. A., Nakano, I., & Wilson, K. F. (2017). The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells. Oncotarget, 8(14), 22325–22343.
toggle visibility
Spencer, D. A., Auffinger, B. M., Murphy, J. P., Muroski, M. E., Qiao, J., Gorind, Y., et al. (2017). Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy. Curr Cancer Drug Targets, 17(3), 236–254.
toggle visibility